D Höffler

Natural products to drugs: natural product-derived compounds in clinical trials

Meloxicam

Biapenem

COX-2 inhibitors

Tobramycin

Ciprofloxacin disk susceptibility tests: interpretive zone size standards for 5-microgram disks

Toxic effects of metals

Minocycline: far beyond an antibiotic

Organization of Ureaplasma urealyticum urease gene cluster and expression in a suppressor strain of Escherichia coli

Lithium and the kidney

Prosthetic Joint Infection

Microbiological and Clinical Aspects of Infection Associated with Stenotrophomonas maltophilia

Ciprofloxacin concentrations in bone and muscle after oral dosing

Ureaplasma urealyticum serotypes in urinary tract disease

Demonstration of mycoplasma in supra-pubic vesicle puncture urine.

Pharmacokinetics of meloxicam in patients with end-stage renal failure on haemodialysis: a comparison with healthy volunteers

[Amoxycillin: pharmacokinetics and experience in the treatment of urinary tract infections].

Dose- and Sex-Independent Disposition of Ciprofloxacin

Nierentoxizität von Lithium bei therapeutischen Dosen

Dose- and sex-independent disposition of ciprofloxacin

Biapenem pharmacokinetics in healthy volunteers and in patients with impaired renal function.

Amoxycillin: Pharmakokinetik und Erfahrungen bei der Behandlung von Harnwegsinfektionen